Butitaxel analogues: synthesis and structure-activity relationships

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Butitaxel is a taxane derivative with potential anticancer properties.
• Developing novel analogues can improve efficacy and reduce side effects.
• Understanding structure-activity relationships is crucial for drug design.

Purpose of the Study:

• To synthesize and characterize novel N-acyl analogues of butitaxel.
• To evaluate the synthesized analogues for their ability to stimulate microtubule formation.
• To assess the cytotoxicity of analogues against B16 melanoma cells and their water solubility.

Main Methods:

• N-Acyl analogues were prepared using Schotten-Baumann acylation.
• Seventeen novel analogues including aliphatic carbamates, alicyclic amides, and heteroaromatic amides were synthesized.
• In vitro assays were used to determine tubulin assembly properties, cytotoxicity, and water solubility.

Main Results:

• Compound 20 (N-debenzoyl-N-(2-thenoyl)butitaxel) was identified as the most potent analogue.
• Compound 20 demonstrated approximately 2-fold better tubulin assembly and cytotoxic activity than paclitaxel.
• Compound 20 exhibited approximately 25-fold greater water solubility compared to paclitaxel.

Conclusions:

• Novel N-acyl butitaxel analogues were successfully synthesized.
• Compound 20 represents a promising lead compound with enhanced anticancer potential and improved physicochemical properties.
• Further investigation of compound 20 is warranted for its therapeutic development.